ERT (Eresearchtechnology, inc.) and Integrium, LLC form alliance to deliver integrated cardiac safety and ambulatory blood pressure monitoring services

ERT (ERESEARCHTECHNOLOGY, INC.) AND INTEGRIUM, LLC FORM ALLIANCE TO DELIVER INTEGRATED CARDIAC SAFETY AND AMBULATORY BLOOD PRESSURE MONITORING SERVICES

PHILADELPHIA, January 30, 2009 - eResearchTechnology, Inc. (ERT), (NASDAQ: ERES - News), and Integrium, LLC announced today their alliance to provide integrated Cardiac Safety and Ambulatory Blood Pressure Monitoring centralized core laboratory services to clinical trial sponsors and managers worldwide.

eResearchTechnology is a leading provider of centralized electrocardiographic (ECG), eClinical technology, ePRO, and other services to the biopharmaceutical , medical device, and related industries. Integrium is a cardiovascular, metabolic disease and dermatology focused clinical research organization (CRO) offering a full range of clinical development services, including Ambulatory Blood Pressure Monitoring (ABPM) centralized core laboratory services.

Under the agreement, ERT and Integrium will deliver a combined solution to meet the increased demand for centralized cardiac safety and ABPM services during clinical trials. The partnership will offer integrated services from project planning and set-up through study conduct, management, and data delivery for primary and secondary Cardiac clinical trial endpoints.

Integrium will provide a full range of ABPM supporting services to include robust & reliable equipment, proprietary analysis software, global on-demand 24/7 attended call center and scientific leadership. ERT will perform digital collection, measurement, interpretation, review, and distribution of cardiac safety data through its EXPERT 2.0 workflow-enabled data management system.

"This alliance addresses a growing need in clinical research to offer comprehensive, best in class services in these two closely related areas of clinical study," said Michael McKelvey, President and CEO of ERT. "While many sponsors recognize and source each company for its respective area of expertise, customers increasingly seek consolidation and streamlining in all phases of a clinical trial. ERT and Integrium approach the market in the same way -- focusing on scientific excellence, providing a quality product, and client satisfaction. We are both metrics driven and process oriented to ensure on-time, on-budget, reliable data delivery on a global scale."